Article
Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Dec 2002
Poljak Mario, Marin Irena J, Seme Katja, Vince Adriana
Abstract excerpt
BACKGROUND: Hybrid Capture II HPV Test (HCII) (Digene Corporation, Gaithersburg, MD) is a signal amplified hybridization microplate-based assay designated to detect 18 human papillomavirus (HPV) genotypes using two probe cocktails, for high-risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68 and low-risk HPV genotypes 6, 11, 42, 43 and 44. At present, HCII is the only commercially available...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.